Cargando…
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
Understanding the mechanisms underlying evasive resistance in cancer is an unmet medical need to improve the efficacy of current therapies. In this study, a combination of shRNA‐mediated synthetic lethality screening and transcriptomic analysis revealed the transcription factors YAP/TAZ as key drive...
Autores principales: | Gao, Ruize, Kalathur, Ravi K R, Coto‐Llerena, Mairene, Ercan, Caner, Buechel, David, Shuang, Song, Piscuoglio, Salvatore, Dill, Michael T, Camargo, Fernando D, Christofori, Gerhard, Tang, Fengyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649869/ https://www.ncbi.nlm.nih.gov/pubmed/34664408 http://dx.doi.org/10.15252/emmm.202114351 |
Ejemplares similares
-
USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis
por: Gao, Ruize, et al.
Publicado: (2021) -
Protocol to screen for Sorafenib resistance regulators using pooled lentiviral shRNA library and a Sorafenib-resistant hepatocellular carcinoma cell model
por: Gao, Ruize, et al.
Publicado: (2023) -
Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching
por: Lüönd, Fabiana, et al.
Publicado: (2021) -
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo‐Independent Regulation of Heat Shock Protein 70 Family Members
por: Coto‐Llerena, Mairene, et al.
Publicado: (2021) -
Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
por: Sun, Tianai, et al.
Publicado: (2020)